FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics and medicine, namely to a pharmaceutical composition regulating the immune response of a living organism, which is a mixture of a nitrogenous heterocyclic compound and fullerenol, where baricitinib is used as nitrogenous heterocyclic compound, and fullerenol C60 is used as fullerenol.
EFFECT: reducing the level of pro-inflammatory cytokines in a living body.
4 cl, 1 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION STIMULATING IMMUNE RESPONSE OF LIVING BODY | 2021 |
|
RU2821633C1 |
| FULLERENOL PRODUCTION METHOD | 2020 |
|
RU2750604C1 |
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
| 2-(3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(ETHYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE HEMINAPHTHYLDISULFONATE AS JANUS KINASE INHIBITOR | 2016 |
|
RU2644155C1 |
| PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2021 |
|
RU2819004C1 |
| NEW SYNTHETIC TLR9 AGONISTS | 2008 |
|
RU2468819C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2387653C2 |
| APPLICATION OF FULLERENE C60 AQUEOUS SOLUTION AS THERAPEUTIC AGENT AT ATOPIC DERMATITIS DISEASE | 2016 |
|
RU2641091C1 |
| PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES | 2009 |
|
RU2493157C2 |
| AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
